929 related articles for article (PubMed ID: 8607395)
1. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
2. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
5. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators.
Anderson JL
Am J Cardiol; 1992 Aug; 70(5):11A-17A; discussion 17A-18A. PubMed ID: 1509993
[TBL] [Abstract][Full Text] [Related]
7. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
Hohnloser SH; Zabel M
Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
[TBL] [Abstract][Full Text] [Related]
10. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
Anderson JL; Jolivette DM; Fredell PA
Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638
[TBL] [Abstract][Full Text] [Related]
11. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P
Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
[TBL] [Abstract][Full Text] [Related]
12. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
14. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials of flecainide acetate in the management of supraventricular arrhythmias.
Camm AJ; Bashir Y
Cardiologia; 1990 Mar; 35(3):193-7. PubMed ID: 2123129
[No Abstract] [Full Text] [Related]
17. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
Kuck KH; Kunze KP; Schlüter M; Duckeck W
Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E; Denjoy I
Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
